CARL ZEISS MEDITEC ADR 1 (AFXA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.068x

Based on the latest financial reports, CARL ZEISS MEDITEC ADR 1 (AFXA) has a cash flow conversion efficiency ratio of 0.068x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€144.16 Million ≈ $168.54 Million USD) by net assets (€2.13 Billion ≈ $2.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of CARL ZEISS MEDITEC ADR 1 to measure how many days the company can operate on defensive assets alone.

CARL ZEISS MEDITEC ADR 1 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how CARL ZEISS MEDITEC ADR 1's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CARL ZEISS MEDITEC ADR 1 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CARL ZEISS MEDITEC ADR 1 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
CENTRAL PUERTO ADR/1 AP1
F:C3TA
0.074x
VIVENDI UNSPON.ARD EO 55
F:VVUD
N/A
Odfjell Drilling Ltd
OL:ODL
0.081x
Pertamina Geothermal Energy
JK:PGEO
0.026x
Tonghua Dongbao Pharmaceutical Co Ltd
SHG:600867
0.009x
Korea Circuit Co. Ltd.
KO:007810
-0.013x
Shenzhen Overseas Chinese Town Co Ltd
SHE:000069
0.045x
Payoneer Global Inc
NASDAQ:PAYO
0.079x

Annual Cash Flow Conversion Efficiency for CARL ZEISS MEDITEC ADR 1 (2022–2025)

The table below shows the annual cash flow conversion efficiency of CARL ZEISS MEDITEC ADR 1 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see CARL ZEISS MEDITEC ADR 1 market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-09-30 €2.13 Billion
≈ $2.49 Billion
€209.86 Million
≈ $245.35 Million
0.099x -17.99%
2024-09-30 €2.06 Billion
≈ $2.40 Billion
€247.32 Million
≈ $289.14 Million
0.120x +4.17%
2023-09-30 €2.17 Billion
≈ $2.54 Billion
€250.86 Million
≈ $293.28 Million
0.115x +24.53%
2022-09-30 €2.03 Billion
≈ $2.37 Billion
€188.20 Million
≈ $220.02 Million
0.093x --

About CARL ZEISS MEDITEC ADR 1

F:AFXA Germany Medical Instruments & Supplies
Market Cap
$2.72 Billion
€2.33 Billion EUR
Market Cap Rank
#6082 Global
#917 in Germany
Share Price
€26.60
Change (1 day)
-1.48%
52-Week Range
€22.40 - €65.00
All Time High
€194.84
About

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, including slit lamps, refractometers, and tonometers; optical coherence tomography and fundus cameras for ret… Read more